Onshore vax manufacture approved

Approval given for AstraZeneca vaccine to be manufactured in Australia The Therapeutic Goods Administration has approved manufacture of the AstraZeneca COVID-19 Vaccine (ChAdOx1-S) in Australia. This follows on from the 16 February 2021 approval by TGA of the overseas-manufactured AstraZeneca vaccine. The vaccine will be manufactured in Australia by CSL - Seqirus, following "extensive work

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous The week in review
Next Wanted: A new groundswell of support